New biotechnology coalition seeks to boost antibiotics development

  17 September 2019

A new coalition of biotechnology stakeholders has formed to promote development of new antibiotics to fight antimicrobial resistance.

Working to Fight AMR launched in August to close the gap in the pharmacological arms race between deadly microbes and antibiotic treatments, the new coalition’s director told HealthLeaders last week.

Further reading: HealthLeadersMedia
Author(s): Christopher Cheney
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!